UBS Group »

Galmed Pharmaceuticals shares owned by UBS Group

Quarter-by-quarter ownership of Galmed Pharmaceuticals (GLMD) shares owned by UBS Group from 13F filings

Historical chart of UBS Group investment in Galmed Pharmaceuticals

Oct 62024Oct 20Nov 3Nov 17Dec 1Dec 15Dec 2925k30k35k550060006500
Value ($)Share countHistorical GLMD position of UBS Group Source: stockzoa.comValue ($)Share count

Tip: Access up to 7 years of quarterly data

All positions including Galmed Pharmaceuticals held by UBS Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Galmed Pharmaceuticals by UBS Group

Quarter filed Position value Share count Share price at filing
2024-12-31 $22k 6.7k 3.33
2024-09-30 $36k 5.3k 6.86

More positions owned by UBS Group

Apple Call Option (AAPL)
NVIDIA Corporation Call Option (NVDA)
Microsoft Corporation Call Option (MSFT)
Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
Amazon Call Option (AMZN)
Broadcom Call Option (AVGO)
Meta Platforms Cl A Call Option (META)
Alphabet Cap Stk Cl A Call Option (GOOGL)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
JPMorgan Chase & Co. Call Option (JPM)
Tesla Motors Call Option (TSLA)
Ubs Group SHS Call Option (UBS)
Alphabet Cap Stk Cl C Call Option (GOOG)
Ishares Tr Russell 2000 Etf (IWM)
Visa Com Cl A Call Option (V)

View all positions for UBS Group

Top funds holding Galmed Pharmaceuticals

Schonfeld Strategic Advisors
Morgan Stanley
UBS Group
Tower Research Capital
Wells Fargo & Company
TSFG
SBI Securities
Federation des caisses Desjardins du Quebec
Advisor Group Holdings
Hanson McClain Advisors
Zrc Wealth Management
Dogwood Wealth Management

View all funds holding Galmed Pharmaceuticals